This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Waterloo directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring.
Diabetes care · 2026 · first author
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.
Diabetes, obesity & metabolism · 2026 · first author
Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation · 2026
Latest funding
- $481,950
Access, Equity, and Real-World Effectiveness of Continuous Glucose Monitoring in Adults with Type 2 Diabetes: A Multi-Provincial Canadian Study
CIHR · 2025 · Nominated PI
31 publications.
Beyond Glycemia: Entering the Era of Hard Outcomes for Continuous Glucose Monitoring.
Alkabbani W, Cromer SJ, Patorno E
Glucagon-Like Peptide-1 Based Therapies and the Risk of Severe Gastrointestinal Motility Adverse Events: A Cohort Study.
Alkabbani W, Crisafulli S, Paik JM, Tavakkoli A, Bykov K, Glynn RJ, Wexler DJ, Patorno E
Safety of Sodium/Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes and CKD.
Ortega-Montiel J, Alkabbani W, Hahn G, Liu J, Byrne CF, Wexler DJ, Patorno E, Paik JM
Methodological considerations in pharmacoepidemiologic analyses of real-world data.
Cromer SJ, Alkabbani W
Web Exclusive. Annals On Call - Dulaglutide, Semaglutide, and Tirzepatide: How Do Gastrointestinal Adverse Effects Compare?
Centor RM, Alkabbani W
Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes.
Crisafulli S, Alkabbani W, Paik JM, Bykov K, Tavakkoli A, Glynn RJ, Htoo PT, Yu EW, Trifirò G, Wexler DJ, Patorno E
Comparative dementia risk with GLP1 receptor agonists, SGLT2 inhibitors, or DPP4 inhibitors: a population-based cohort study.
Wu CY, Alkabbani W, Shah BR, Kapral MK, Edwards JD, Maxwell CJ, Swardfager W
Neovascular Age-Related Macular Degeneration and GLP-1 RAs.
Alkabbani W, Cromer SJ, Patorno E
Letter to the Editor.
Cromer SJ, Alkabbani W, Patorno E
Insulin, hypoglycaemia and dementia: A causal mediation analysis showcasing challenges and potential opportunities.
Alkabbani W, Maxwell CJ, Marrie RA, Tyas SL, Lega IC, Gamble JM
Access, Equity, and Real-World Effectiveness of Continuous Glucose Monitoring in Adults with Type 2 Diabetes: A Multi-Provincial Canadian Study
Principal investigators: Alkabbani, wajd; Maxwell, Colleen J
Keywords: Access To Care; Comparative Effectiveness Research; Continuous Glucose Monitoring; Diabetes Technology; Health Equity And Disparities; Health Policy; Hypoglycemia; Real-World Evidence; Social Determinants Of Health; Type 2 Diabetes Mellitus
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- School of Pharmacy
- Oncology
- Family Medicine
- Health Policy and Management
- Department of Pharmacology and Toxicology
- Other
Co-authors at University of Waterloo, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
John-Michael Gamble
School of Pharmacy
19 shared papers, latest 2024
Tejal Patel
School of Pharmacy
2 shared papers, latest 2024
Linda Lee
School of Pharmacy
2 shared papers, latest 2024
Linda Lee
Oncology
2 shared papers, latest 2024
Arsene Zongo
Faculty
1 shared papers, latest 2021
Matthias Hoben
Faculty
1 shared papers, latest 2024
Matthias Hoben
Health Policy and Management
1 shared papers, latest 2024
Andrea Gruneir
Faculty
1 shared papers, latest 2024
Walter Swardfager
Department of Pharmacology and Toxicology
1 shared papers, latest 2025
Andrea Gruneir
Family Medicine
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.